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The signiﬁcance of hepatitis B virus (HBV) DNA-based integration in hepatocarcinogenesis is poorly
understood. In the present study, we investigated whether the integration of HBV X gene (HBx) is
involved in the event. Our ﬁnding showed that the integration of HBx fragment (316–462 bp/262–
462 bp) was able to transform human immortalized normal liver LO2 cells using a cell model of
HBx-integration. We identiﬁed that the recombination, HBx/Alu core sequence/subtelomeric DNA,
was required for the transformation, which could be detected in 5 out of 44 clinical HBx-positive
hepatocellular carcinoma tissues. Thus, we conclude that HBx integration is involved in the
hepatocarcinogenesis.
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction [6]. The ﬁnding of HBV DNA integration into human liver DNA in al-Generally, hepatitis B virus (HBV) infection is closely related to
the development of hepatocellular carcinoma (HCC), in which the
HBV X gene (HBx) plays a crucial role [1,2]. Most researches
focused on the role of HBx in hepatocarcinogenesis. However, the
mechanism of HBV-induced HCC is complicated and remains un-
clear [2–5]. HBV DNA can randomly integrate into the host genome
at various stages of chronic HBV infection with a very high integra-
tion rate of more than 80% in HBV-related HCC, in whichmost of the
open reading frame of the X gene is preserved in the host genomechemical Societies. Published by E
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B; hTERT, human telomerase
T-PCR, reverse-transcription
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, yelihong@nankai.edu.cn (L.most all HBV-related HCC suggested that HBV DNA integration in
the host genome may be involved in the liver oncogenesis [6–9].
Up to now, all reports involving HBV DNA integration imply that
the integration should play a role in the transformation. More, there
is no direct evidence to support the hypothesis that HBV DNA inte-
gration in the host genome is able to result in hepatocarcinogenesis.
Previously, we reported that human immortalized liver L-O2 cells
were transformed in a model of stably HBx gene-transfection [10].
However, the signiﬁcance of HBx integration in the host genome
of hepatoma cells in hepatocarcinogenesis is not fully understood.
In this study, we address whether HBx integration is involved in
the hepatocarcinogenesis. Surprisingly, we observed that the HBx
integration was related to the transformation of L-O2 cells after
ruling out the possibility of trans-activation of HBx protein in the
hepatocarcinogenesis. Our ﬁnding provides new insight into the
signiﬁcance of HBx integration in hepatocarcinogenesis.
2. Materials and methods
The details of methods are described in Supplementary
methods.lsevier B.V. All rights reserved.
Fig. 1. A model of stably HBx-mutant transfected cell line is established. (A) A model of HBx fragments. (B) The expression of HBx mRNA of the engineered expression vectors
were examined by RT-PCR. (C) The promoter activities of NF-jB and hTERT in L-O2 cells transiently transfection with HBx fragments in time course manner were detected by
luciferase reporter gene assay (⁄⁄P < 0.01, vs mock, Student’s t test).
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The human liver cell line L-O2 (Nanjing KeyGen Biotech Co.
Ltd., China), originating from normal human liver tissue, was
immortalized by stable transfection of human telomerase reverse
transcriptase (hTERT) gene and cultured as previously described
[10–13]. L-O2, L-O2-P (L-O2 stably transfected with pcDNA3 vec-
tor), L-O2-X (L-O2 stably transfected with the HBx gene), human
HCC H7402 cell line, H7402-P (H7402 stably transfected with
pcDNA3 vector) and H7402-X (H7402 stably transfected with the
HBx gene) cells were cultured in RPMI 1640 (Gibco, USA) with
10% fetal calf serum (FCS) [4,14,15]. HepG2.2.15 (a hepatoma
HepG2 cell line integrated full-length HBV DNA) [16], HepG2-X
(HepG2 stably transfected with the HBx gene) and 3T3-X (NIH3T3
stably transfected with the HBx gene) [16] were cultured in DMEM
medium (Gibco, USA) with 10% FCS. HCC tissues and non-tumor
tissues were obtained from 60 patients (55 males and 5 females
aged 20–69 years, with an average age of 50.9) who underwent to-
tal or partial hepatectomies in Zhongshan Hospital, Guangzhou,
China.
2.2. Statistical analysis
Statistical analysis was performed using SigmaPlot 2001 (Systat
Software Inc., Richmond, CA, http://www.systat.com). Statistical
signiﬁcance was assessed by comparing mean values (±S.D.) usinga Student’s t test for independent groups and was assumed for
P < 0.05 (⁄), P < 0.01 (⁄⁄) and P < 0.001 (⁄⁄⁄).
3. Results
3.1. A model of stably HBx-mutant transfected cell line is established
To establish the cell models integrated with HBx-mutant, which
lost the trans-activation function, we randomly divided the full-
length HBx gene into ﬁve fragments (Fig. 1A) and established the
engineered cells termed L-O2-X1, L-O2-X2, L-O2-X3, L-O2-X4 and
L-O2-X5 (or H7402-X1, H7402-X2, H7402-X3, H7402-X4 and
H7402-X5), respectively. Meanwhile, we found that all the 5 HBx
mutants could be detected at the mRNA level in L-O2 cells in tran-
sient transfection system (Fig. 1B), suggesting that the vectors are
able to express HBx mutants in the cells. It was undetectable for
the HBx mutants at the protein level by western blot. Then, to
show whether the HBx mutants have function in trans-activation,
we observed the effect of HBx mutant proteins on the promoter
activities of NF-jB and hTERT by luciferase reporter gene assay
in transient transfection system, because wild type HBx is able to
effectively regulate the expression of NF-jB and hTERT in L-O2
cells [14]. Our data displayed that overexpression of the 5 frag-
ments of HBx gene failed to affect the promoter activities of NF-
jB and hTERT within 48 or 72 h (Fig. 1C). Thus, we conclude that
the mutant HBx proteins lost the trans-activation roles. Therefore,
Fig. 2. The engineered L-O2-X3 and L-O2-X5 cell lines show the malignant phenotype of tumor cells. (A) The transcriptional activities of NF-jB, AP-1 and hTERT were
examined by luciferase reporter gene assay in the engineered cells. Values represent mean ± SD (n = 3). ⁄⁄P < 0.01, vs L-O2 or H7402 cells; ⁄⁄⁄P < 0.001, vs. L-O2 or H7402 cells,
by Student’s t test. (B) Expression levels of c-Myc and Bcl-2 were examined in the engineered L-O2 cells by Western blot analysis. ⁄P < 0.05, Student’s t test. (C) Expression
levels of c-Myc and Bcl-2 were examined in the engineered H7402 cells by Western blot analysis. The intensity for each band was densitometrically quantiﬁed. ⁄P < 0.05,
Student’s t test.
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3.2. Integration of HBx fragment (316–465 bp or 262–465 bp)
increases malignant phenotype of liver and hepatoma cells
We further observed the malignant phenotype of stably HBx
fragment transfected engineered cells at the molecular level. Inter-
estingly, we observed that the promoter activities of NF-jB, AP-1
and hTERT were increased only in the engineered cells L-O2-X,
L-O2-X3 and L-O2-X5 (or H7402-X, H7402-X3 and H7402-X5),
but others were not (Fig. 2A). The results showed that the pro-
moter of NF-jB (or AP-1 and hTERT) was activated in the L-O2-X,
L-O2-X3 and L-O2-X5 (or H7402-X, H7402-X3 and H7402-X5)
cells, but not in others, suggesting that the malignant phenotype
of the cell lines was enhanced by the integration of HBx fragment
3 (fragment 5), rather than the HBx mutants themselves. The pro-
teins involved in proliferation and transformation, such as c-Myc
and Bcl-2 were remarkably up-regulated in the corresponding cells
as well (Fig. 2B and C). Thus, we conclude that the HBx integration
is involved in the transformation of L-O2 cells.
Next, we provided more evidence that HBx integration was in-
volved in transformation in vitro and in vivo. AFP (a known bio-
marker of HCC) was detectable in the L-O2-X3 and L-O2-X5 cells
(Fig. 3A). Moreover, the two cell lines (or H7402-X3 and H7402-
X5 cell lines) generated more clones in soft agar (Fig. 3B). Surpris-
ingly, animal transplantation showed that 5 out of 8 nude mice
injected with L-O2-X3 cells and 3 out of 8 nude mice injected with
L-O2-X5 cells gave rise to tumors after transplantation, while the
others failed to form any visible tumors (Fig. 3C). Consistently,pathological observation showed that all 8 primary tumors dis-
played malignant phenotypes by H&E staining (Fig. 3D). In addi-
tion, AFP was detectable in above all 8 primary tumors (Fig. 3D).
Then, to rule out the possibility that trans-activation of HBx
mutant proteins acts in tumor formation, we silenced the HBx mu-
tant mRNAs by transient transfection with pSilencer-HBx plasmid
into L-O2-X5 cells. The animal transplantation analysis showed
that 3 out of 8 nude mice injected with L-O2-X5 cells still formed
tumors (Fig. 3E), suggesting that the HBx mutant protein is not in-
volved in the tumor formation. Thus, we conclude that HBx inte-
gration is involved in the transformation of L-O2 cells.
3.3. A HBx/Alu core sequence/subtelomeric DNA is Identiﬁed
To identify the HBx integration manner in the host genome of
cells, we performed the HBx-Alu PCR.[17] The positive PCR prod-
ucts were showed in Fig. 4A. The products were linked into T vec-
tor, which were sequenced individually. Interestingly, one of
sequencing data revealed that the HBx gene inserted at the up-
stream of a 20 bp Alu core sequence with a secondary deletion of
382–465 bp at the 30 end of HBx gene, followed by subtelomeric
DNA (Genbank No. Z96142.1) (Fig. 4B), suggesting that HBx inte-
gration results in a recombination of HBx/Alu core sequence/subt-
elomeric DNA in the host genome. Accordingly, we designed the
PCR primers to amplify the sequence from the integrated HBx to
subtelomeric DNA, to conﬁrm the recombination in other cell lines,
such as H7402-X, 3T3-X, HepG2.2.15 and HepG2-X. We used the
primers, such as HB1 (from 1 bp of HBx gene N-terminal) and
Alu (from Alu sequence) to identify the integration. However, we
failed to obtain the positive results. We had to use the primer
Fig. 3. The engineered L-O2-X3 and L-O2-X5 cell lines were transformed. (A) AFP was detected by western blot analysis in the engineered cell lines. (B) Soft agar colony
formation assay was used to examine the malignant phenotype of the engineered cell lines. The colonies were counted and plotted as percentages of L-O2 or H7402 cell
controls (⁄P < 0.05, vs H7402 cells; ⁄⁄P < 0.01, vs L-O2 or H7402 cells, Student’s t test). (C) Tumorigenicity of the engineered L-O2 cell lines was examined in nude mice. (D)
H&E stained sections (100) of primary tumors described above displayed malignant phenotypes. AFP expression was examined in all primary tumor tissues by
immunohistochemistry and western blot. (E) Tumorigenicity of the engineered L-O2-X5 cell line was examined in nude mice. HBx mRNA was silenced in the cells by transient
tansfection of pSilenser-HBx.
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this way, the same PCR product and recombination could be de-
tected by sequencing in H7402-X cells (Fig. 4C and D), but the oth-
ers were not (data not shown), suggesting that the possibilities of
the recombination are not too much. Moreover, we observed the
HBx positive signals in the terminals of chromosomes through FISH
assay (Fig. 4E). Thus, we identify a novel recombination involving
HBx/Alu core sequence/subtelomeric DNA in the host genome from
the transformed cells.
3.4. HBx/Alu core sequence/subtelomeric DNA is associated with the
transformation
After identifying the recombination involving HBx/Alu core se-
quence/subtelomeric DNA, we are interested in the relationship
between the recombination and transformation mediated by HBx
integration in L-O2 cells. Then, we examined the recombination
in above ten engineered cell lines by PCR using the primers from
each of the ﬁve fragments to subtelomeric DNA. Incredibly, we ob-
served that the recombination was only found in the transformed
L-O2-X3 and L-O2-X5 (or H7402-X3 and H7402-X5) cells but not
in the non-transformed cells (Fig. 5A). However, the Alu core
sequence was missing in the recombination sequence in H7402-
X3 and H7402-X5 cells (Fig. 5B). The corresponding recombinationmatched the L-O2-X3 and L-O2-X5 cell lines (Fig. 5B), suggesting
that the recombination involving HBx gene/Alu core sequence/
subtelomeric DNA is associated with the transformation mediated
by HBx integration.
Then, we examine the recombination in clinical HBV-related
HCC tissues. We ﬁrst checked the HBx gene in 60 cases of HCC
tissues and their non-tumor ones by PCR. The positive rates of
HBx gene were 73.3% (44/60) in HCC tissues and 73.3% (44/60) in
their non-tumor tissues. Then, we detected the recombination of
HBx/Alu core sequence/subtelomeric DNA in the above HBx-posi-
tive tissues by PCR using the primers from HBx to subtelomeric
DNA. Interestingly, the recombination was detectable in 5 out of
44 cases HCC tissues, while in their non-tumor tissues the recom-
bination was negative (Fig. 6A and B). Indeed, the recombination
involving HBx/Alu core sequence/subtelomeric DNA occurs in the
clinical HCC tissues. The serum data had no signiﬁcant difference
between the 5 cases and others. Thus, the evidence supports that
the above recombination is associated with hepatocarcinogenesis.
4. Discussion
Hepatitis B virus X protein plays crucial roles in the develop-
ment of HCC. However, the signiﬁcance of HBx-based integration
in hepatocarcinogenesis is poorly understood. It has been reported
Fig. 4. A recombination of the HBx/Alu core sequence/subtelomeric is identiﬁed. (A,B) HBx-Alu PCR showed the PCR products from L-O2-X cells. One sequence of HBx-Alu PCR
products showed that the HBx gene (bold) integrated at the upstream of the 20 bp Alu core sequence (framed by box), followed by the subtelomeric DNA sequence
(underlined). A secondary deletion of 382–465 bp of HBx gene at the 30 end was found at the integration site. (C,D) HBx-mediated recombination was identiﬁed in H7402-X
cells by PCR. H7402 cells were used as negative control and L-O2-X cells as positive control. The model showed the sequence results of HBx-Alu PCR products in LO2-X and
H7402-X cells. (E) HBx integration sites in the chromosomes of L-O2-X cells were detected by FISH analysis. The hybridization positive signals are visible as red.
Fig. 5. The HBx meditated-recombination is observed in L-O2-X3/L-O2-X5 (or H7402-X3/H7402-X5) cells. (A) The HBx-mediated recombination in L-O2-X3/L-O2-X5 (or
H7402-X3/ H7402-X5) cells was examined by HBx-Alu PCR. (B) The sequences from the engineered cells were aligned with the corresponding HBx fragment.
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sites in the genome [8,18], such as hTERT gene [19,20], NTRK2,
IRAK2, p42MAPK1, IP3R2, IP3R1, ST3GAL VI or SITA, TRUP and
EMX2-like genes [20]. Up to now, all reports involved in HBV
DNA integration have considered that the integration is very
important event in hepatocarcinogenesis, but no evidence to sup-
port the hypothesis [8,18–20]. Thus, we are interested in the signif-
icance of HBx gene integration in hepatocarcinogenesis.
In this study, we investigated the signiﬁcance of HBx gene inte-
gration in oncogenesis by using a cell model of HBx-mutant inte-
gration. We ﬁrst established several cell models integrated with
HBx fragments which lost trans-activation although could be ex-
pressed in the cells. We found that two out of ﬁve engineered
L-O2 cell lines with HBx mutant gene-integration (L-O2-X3 andL-O2-X5 cell lines) displayed malignant phenotype in vivo &
in vitro (Fig. 1–3). However, the engineered cell lines of L-O2-X1,
L-O2-X2 and L-O2-X4 did not show the malignant phenotype, sug-
gesting that not all integration of HBV DNA is able to result in the
transformation. In other words, the fragments of HBx, such as frag-
ment 1, 2 and 4, may serve as negative controls in the experiments
of integration of HBx in the cells. The NF-jB signaling pathway is
important in several liver diseases such as hepatitis, liver cirrhosis
and HCC [21], which is often activated in HCC associated with hep-
atitis [22]. Activation of AP-1 protein leads to cell proliferation and
survival effects by regulating the expression and function of a
number of genes [23]. Therefore, to provide evidence of transfor-
mation mediated by HBx integration at the molecular level, we
showed that HBx integration described above was associated with
Fig. 6. The HBx-meditated recombination is identiﬁed in clinical HCC tissues. (A) HBx-mediated recombination was identiﬁed by PCR in 44 cases of HBx-positive HCC tissues
and non-tumor tissues; C3–C12: HCC specimens 3–12; N3–N12: corresponding non-tumor specimens 3–12; (+): The genome of L-O2-X cells was used as a positive control.
(): The genome of L-O2 cells was used as a negative control. Other negative results are not shown. (B) Sequences from HBx-mediated recombination in HCC tissues were
shown, in which sequences from HCC tissues are aligned with those from the L-O2-X and H7402-X cell lines.
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(Fig. 2A). The proteins, such as c-Myc and Bcl-2, involved in prolif-
eration and transformation were remarkably upregulated in the
corresponding cells as well (Fig. 2B). These suggest that HBx inte-
gration in host genome is involved in the liver cell transformation.
Then, we identiﬁed the HBx-mutant integration sites by HBx-
Alu PCR approach. Interestingly, we identiﬁed a fragile site, which
resulted in a recombination of HBx/Alu core sequence/subtelomer-
ic DNA (Fig. 4B). Moreover, we observed positive signals of HBx-
mutant integration in the terminals of chromosome using FISH in
the engineered L-O2-X cells (Fig. 4E). We examined the integration
of the fragments of HBx by other method, such southern blot, but
we failed to gain the positive signals. The reason may be related to
that the copies of the HBx mutant integrated in the genome of cells
are too few to detect, according to that FISH positive signals are
few (Fig. 4E). This observation supports the ﬁnding of above
recombination. The HBx gene integration positive signals were ob-
served in several points in chromosome of cells, suggesting that
HBx is able to integrate multiple sites. The recombination of
HBx/Alu core sequence/subtelomeric DNA is one of possibilities.
The 26 bp Alu core sequence functions as a recombination hotspot
[24]. An abnormal CAD gene with its exon 3 replaced by a trun-
cated transposable Alu repeat is present in HCC Hep3B cell line
[25], which showing a signiﬁcant role of Alu-mediated genomic
mutation in hepatocarcinogenesis. The subtelomeric regions of
chromosomes are structurally complex regions of the human gen-
ome, which are unusually dynamic as a rich source of genetic var-
iability; thus, chromosomal rearrangements occur more frequently
in subtelomeric regions [26,27]. Some tumor cells use alternative
lengthening of telomeres (ALT) to maintain telomere length in a
telomerase-independent mechanism through rearrangement of
subtelomeric regions [28]. Thus, we hypothesized that the HBx-
mediated recombination of HBx/Alu core sequence/subtelomeric
DNA may be related to hepatocarcinogenesis. Therefore, we exam-
ined the recombination in the cell lines stably transfected with
full-length HBx or non-functional HBx fragments. Interestingly,
the recombination was just found in L-O2-X3 and L-O2-X5 (or
H7402-X3 and H7402-X5) cells that were transformed (Fig. 5A
and B). These suggest that the recombination mediated by HBx
integration may be involved in the transformation of L-O2 cells.
However, the Alu core sequence was missing in the recombinant
sequence in H7402-X3 and H7402-X5 cells. It has been shown that
HBx alone is not able to induce tumor development in nude micewhen using NIH3T3 cells as a model [29]. Indeed, in our study
we failed to identify the described recombination in engineered
3T3-X cells. Thus, we believe that the different integration patterns
of the HBx gene, such as those involving the Alu core sequence and
subtelomeric DNA in different host cells may be responsible for the
different results in transformation mediated by HBx between the
two models.
Interestingly, it has been reported that HBV DNA could insert
into the Alu sequence (20 out of 68 cases), but the role of the inser-
tion at this site was not clear [30]. Our ﬁnding is consistent with
the report, i.e., HBx gene could be detected at the upstream of
Alu core sequence in 5 out of 44 cases of HCC tissues (Fig. 6A and
B). Although the number of these cases was low, interestingly, 2
out of 5 patients with the HBx-mediated recombination had only
a 2 or 3 years history of HBV infection according to the clinical
information. These data further supported that the recombination
of HBx/Alu core sequence/subtelomeric DNA may be involved in
the hepatocarcinogenesis, although other random HBV integration
sites may exist in HCC. The ﬁnding suggests that the recombination
of HBx/Alu core sequence/subtelomeric DNA is one of the risk
events in the development of HCC, which may be used for diagno-
sis of HCC in clinic. It strongly suggests that the prevention of HBV
infection is very important.
Taken together, we ﬁrst report that the integration of HBx is in-
volved in the hepatocarcinogenesis. A recombination of HBx/Alu
core sequence/subtelomeric DNA mediated by HBx integration
may be associated with the event. This ﬁnding provides new
insights into the signiﬁcance of HBx integration in the
hepatocarcinogenesis.Acknowledgments
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